nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Imiquimod—skin cancer	0.119	0.233	CbGbCtD
Cevimeline—CYP3A4—Temozolomide—skin cancer	0.119	0.233	CbGbCtD
Cevimeline—CYP2D6—Vemurafenib—skin cancer	0.102	0.201	CbGbCtD
Cevimeline—CYP3A4—Vismodegib—skin cancer	0.0824	0.162	CbGbCtD
Cevimeline—CYP3A4—Vemurafenib—skin cancer	0.0651	0.128	CbGbCtD
Cevimeline—CYP3A4—Docetaxel—skin cancer	0.0223	0.0438	CbGbCtD
Cevimeline—Urticaria—Imiquimod—skin cancer	0.000321	0.000655	CcSEcCtD
Cevimeline—Body temperature increased—Imiquimod—skin cancer	0.000319	0.000651	CcSEcCtD
Cevimeline—Abdominal pain—Imiquimod—skin cancer	0.000319	0.000651	CcSEcCtD
Cevimeline—Eye disorder—Temozolomide—skin cancer	0.000318	0.00065	CcSEcCtD
Cevimeline—Tinnitus—Temozolomide—skin cancer	0.000318	0.000648	CcSEcCtD
Cevimeline—Malaise—Bleomycin—skin cancer	0.000317	0.000647	CcSEcCtD
Cevimeline—Cardiac disorder—Temozolomide—skin cancer	0.000316	0.000645	CcSEcCtD
Cevimeline—Flushing—Temozolomide—skin cancer	0.000316	0.000645	CcSEcCtD
Cevimeline—Haemoglobin—Fluorouracil—skin cancer	0.000316	0.000644	CcSEcCtD
Cevimeline—Leukopenia—Bleomycin—skin cancer	0.000315	0.000642	CcSEcCtD
Cevimeline—Rhinitis—Fluorouracil—skin cancer	0.000315	0.000642	CcSEcCtD
Cevimeline—Haemorrhage—Fluorouracil—skin cancer	0.000314	0.00064	CcSEcCtD
Cevimeline—Dizziness—Vemurafenib—skin cancer	0.000313	0.000639	CcSEcCtD
Cevimeline—Hypoaesthesia—Fluorouracil—skin cancer	0.000312	0.000637	CcSEcCtD
Cevimeline—Pharyngitis—Fluorouracil—skin cancer	0.000312	0.000636	CcSEcCtD
Cevimeline—Angiopathy—Temozolomide—skin cancer	0.000309	0.000631	CcSEcCtD
Cevimeline—Cough—Bleomycin—skin cancer	0.000307	0.000626	CcSEcCtD
Cevimeline—Chills—Temozolomide—skin cancer	0.000306	0.000624	CcSEcCtD
Cevimeline—Dehydration—Docetaxel—skin cancer	0.000305	0.000621	CcSEcCtD
Cevimeline—Ill-defined disorder—Dactinomycin—skin cancer	0.000304	0.000621	CcSEcCtD
Cevimeline—Anaemia—Dactinomycin—skin cancer	0.000303	0.000618	CcSEcCtD
Cevimeline—Vomiting—Vemurafenib—skin cancer	0.000301	0.000614	CcSEcCtD
Cevimeline—Alopecia—Temozolomide—skin cancer	0.000301	0.000614	CcSEcCtD
Cevimeline—Dry skin—Docetaxel—skin cancer	0.0003	0.000612	CcSEcCtD
Cevimeline—Myalgia—Bleomycin—skin cancer	0.000299	0.000611	CcSEcCtD
Cevimeline—Chest pain—Bleomycin—skin cancer	0.000299	0.000611	CcSEcCtD
Cevimeline—Orthostatic hypotension—Docetaxel—skin cancer	0.000299	0.00061	CcSEcCtD
Cevimeline—Rash—Vemurafenib—skin cancer	0.000299	0.000609	CcSEcCtD
Cevimeline—Dermatitis—Vemurafenib—skin cancer	0.000298	0.000609	CcSEcCtD
Cevimeline—Hypersensitivity—Imiquimod—skin cancer	0.000298	0.000607	CcSEcCtD
Cevimeline—Headache—Vemurafenib—skin cancer	0.000297	0.000605	CcSEcCtD
Cevimeline—Malnutrition—Temozolomide—skin cancer	0.000297	0.000605	CcSEcCtD
Cevimeline—Discomfort—Bleomycin—skin cancer	0.000296	0.000603	CcSEcCtD
Cevimeline—Malaise—Dactinomycin—skin cancer	0.000296	0.000603	CcSEcCtD
Cevimeline—Leukopenia—Dactinomycin—skin cancer	0.000294	0.000599	CcSEcCtD
Cevimeline—Dysgeusia—Temozolomide—skin cancer	0.00029	0.000593	CcSEcCtD
Cevimeline—Asthenia—Imiquimod—skin cancer	0.00029	0.000591	CcSEcCtD
Cevimeline—Confusional state—Bleomycin—skin cancer	0.000289	0.00059	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000289	0.000589	CcSEcCtD
Cevimeline—Oedema—Bleomycin—skin cancer	0.000287	0.000585	CcSEcCtD
Cevimeline—Back pain—Temozolomide—skin cancer	0.000287	0.000585	CcSEcCtD
Cevimeline—Pruritus—Imiquimod—skin cancer	0.000286	0.000583	CcSEcCtD
Cevimeline—Infection—Bleomycin—skin cancer	0.000285	0.000582	CcSEcCtD
Cevimeline—Dysphagia—Docetaxel—skin cancer	0.000283	0.000577	CcSEcCtD
Cevimeline—Nausea—Vemurafenib—skin cancer	0.000281	0.000574	CcSEcCtD
Cevimeline—Thrombocytopenia—Bleomycin—skin cancer	0.000281	0.000573	CcSEcCtD
Cevimeline—Arrhythmia—Fluorouracil—skin cancer	0.00028	0.000572	CcSEcCtD
Cevimeline—Myalgia—Dactinomycin—skin cancer	0.000279	0.00057	CcSEcCtD
Cevimeline—Bronchospasm—Docetaxel—skin cancer	0.000278	0.000568	CcSEcCtD
Cevimeline—Tremor—Temozolomide—skin cancer	0.000278	0.000567	CcSEcCtD
Cevimeline—Alopecia—Fluorouracil—skin cancer	0.000277	0.000566	CcSEcCtD
Cevimeline—Diarrhoea—Imiquimod—skin cancer	0.000276	0.000564	CcSEcCtD
Cevimeline—Discomfort—Dactinomycin—skin cancer	0.000276	0.000563	CcSEcCtD
Cevimeline—Angina pectoris—Docetaxel—skin cancer	0.000276	0.000563	CcSEcCtD
Cevimeline—Ill-defined disorder—Temozolomide—skin cancer	0.000275	0.000561	CcSEcCtD
Cevimeline—Anaemia—Temozolomide—skin cancer	0.000274	0.000559	CcSEcCtD
Cevimeline—Anorexia—Bleomycin—skin cancer	0.000274	0.000558	CcSEcCtD
Cevimeline—Agitation—Temozolomide—skin cancer	0.000273	0.000556	CcSEcCtD
Cevimeline—Hypotension—Bleomycin—skin cancer	0.000268	0.000547	CcSEcCtD
Cevimeline—Oedema—Dactinomycin—skin cancer	0.000268	0.000546	CcSEcCtD
Cevimeline—Malaise—Temozolomide—skin cancer	0.000268	0.000546	CcSEcCtD
Cevimeline—Dizziness—Imiquimod—skin cancer	0.000267	0.000545	CcSEcCtD
Cevimeline—Vertigo—Temozolomide—skin cancer	0.000267	0.000544	CcSEcCtD
Cevimeline—Infection—Dactinomycin—skin cancer	0.000266	0.000542	CcSEcCtD
Cevimeline—Leukopenia—Temozolomide—skin cancer	0.000266	0.000542	CcSEcCtD
Cevimeline—Palpitations—Temozolomide—skin cancer	0.000262	0.000535	CcSEcCtD
Cevimeline—Thrombocytopenia—Dactinomycin—skin cancer	0.000262	0.000535	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000261	0.000533	CcSEcCtD
Cevimeline—Cough—Temozolomide—skin cancer	0.000259	0.000528	CcSEcCtD
Cevimeline—Paraesthesia—Bleomycin—skin cancer	0.000258	0.000526	CcSEcCtD
Cevimeline—Weight increased—Docetaxel—skin cancer	0.000258	0.000526	CcSEcCtD
Cevimeline—Convulsion—Temozolomide—skin cancer	0.000257	0.000524	CcSEcCtD
Cevimeline—Vomiting—Imiquimod—skin cancer	0.000257	0.000524	CcSEcCtD
Cevimeline—Weight decreased—Docetaxel—skin cancer	0.000256	0.000522	CcSEcCtD
Cevimeline—Hypertension—Temozolomide—skin cancer	0.000256	0.000522	CcSEcCtD
Cevimeline—Dyspnoea—Bleomycin—skin cancer	0.000256	0.000522	CcSEcCtD
Cevimeline—Anorexia—Dactinomycin—skin cancer	0.000255	0.00052	CcSEcCtD
Cevimeline—Rash—Imiquimod—skin cancer	0.000255	0.00052	CcSEcCtD
Cevimeline—Dermatitis—Imiquimod—skin cancer	0.000254	0.000519	CcSEcCtD
Cevimeline—Pneumonia—Docetaxel—skin cancer	0.000254	0.000518	CcSEcCtD
Cevimeline—Headache—Imiquimod—skin cancer	0.000253	0.000516	CcSEcCtD
Cevimeline—Anaemia—Fluorouracil—skin cancer	0.000253	0.000515	CcSEcCtD
Cevimeline—Arthralgia—Temozolomide—skin cancer	0.000253	0.000515	CcSEcCtD
Cevimeline—Myalgia—Temozolomide—skin cancer	0.000253	0.000515	CcSEcCtD
Cevimeline—Anxiety—Temozolomide—skin cancer	0.000252	0.000513	CcSEcCtD
Cevimeline—Discomfort—Temozolomide—skin cancer	0.00025	0.000509	CcSEcCtD
Cevimeline—Decreased appetite—Bleomycin—skin cancer	0.000249	0.000509	CcSEcCtD
Cevimeline—Acute coronary syndrome—Docetaxel—skin cancer	0.000249	0.000508	CcSEcCtD
Cevimeline—Neuropathy peripheral—Docetaxel—skin cancer	0.000247	0.000505	CcSEcCtD
Cevimeline—Myocardial infarction—Docetaxel—skin cancer	0.000247	0.000505	CcSEcCtD
Cevimeline—Stomatitis—Docetaxel—skin cancer	0.000246	0.000502	CcSEcCtD
Cevimeline—Pain—Bleomycin—skin cancer	0.000245	0.000501	CcSEcCtD
Cevimeline—Conjunctivitis—Docetaxel—skin cancer	0.000245	0.000501	CcSEcCtD
Cevimeline—Leukopenia—Fluorouracil—skin cancer	0.000245	0.000499	CcSEcCtD
Cevimeline—Confusional state—Temozolomide—skin cancer	0.000244	0.000498	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000244	0.000497	CcSEcCtD
Cevimeline—Oedema—Temozolomide—skin cancer	0.000242	0.000494	CcSEcCtD
Cevimeline—Infection—Temozolomide—skin cancer	0.000241	0.000491	CcSEcCtD
Cevimeline—Nausea—Imiquimod—skin cancer	0.00024	0.000489	CcSEcCtD
Cevimeline—Epistaxis—Docetaxel—skin cancer	0.000238	0.000486	CcSEcCtD
Cevimeline—Nervous system disorder—Temozolomide—skin cancer	0.000237	0.000484	CcSEcCtD
Cevimeline—Thrombocytopenia—Temozolomide—skin cancer	0.000237	0.000484	CcSEcCtD
Cevimeline—Convulsion—Fluorouracil—skin cancer	0.000237	0.000483	CcSEcCtD
Cevimeline—Feeling abnormal—Bleomycin—skin cancer	0.000237	0.000482	CcSEcCtD
Cevimeline—Agranulocytosis—Docetaxel—skin cancer	0.000236	0.000481	CcSEcCtD
Cevimeline—Skin disorder—Temozolomide—skin cancer	0.000235	0.00048	CcSEcCtD
Cevimeline—Hyperhidrosis—Temozolomide—skin cancer	0.000234	0.000477	CcSEcCtD
Cevimeline—Chest pain—Fluorouracil—skin cancer	0.000233	0.000475	CcSEcCtD
Cevimeline—Myalgia—Fluorouracil—skin cancer	0.000233	0.000475	CcSEcCtD
Cevimeline—Decreased appetite—Dactinomycin—skin cancer	0.000233	0.000475	CcSEcCtD
Cevimeline—Fatigue—Dactinomycin—skin cancer	0.000231	0.000471	CcSEcCtD
Cevimeline—Anorexia—Temozolomide—skin cancer	0.000231	0.000471	CcSEcCtD
Cevimeline—Discomfort—Fluorouracil—skin cancer	0.00023	0.000469	CcSEcCtD
Cevimeline—Pain—Dactinomycin—skin cancer	0.000229	0.000467	CcSEcCtD
Cevimeline—Urticaria—Bleomycin—skin cancer	0.000228	0.000465	CcSEcCtD
Cevimeline—Haemoglobin—Docetaxel—skin cancer	0.000228	0.000465	CcSEcCtD
Cevimeline—Rhinitis—Docetaxel—skin cancer	0.000227	0.000463	CcSEcCtD
Cevimeline—Body temperature increased—Bleomycin—skin cancer	0.000227	0.000463	CcSEcCtD
Cevimeline—Haemorrhage—Docetaxel—skin cancer	0.000227	0.000462	CcSEcCtD
Cevimeline—Hypoaesthesia—Docetaxel—skin cancer	0.000225	0.00046	CcSEcCtD
Cevimeline—Confusional state—Fluorouracil—skin cancer	0.000225	0.000459	CcSEcCtD
Cevimeline—Pharyngitis—Docetaxel—skin cancer	0.000225	0.000459	CcSEcCtD
Cevimeline—Oedema peripheral—Docetaxel—skin cancer	0.000223	0.000455	CcSEcCtD
Cevimeline—Oedema—Fluorouracil—skin cancer	0.000223	0.000455	CcSEcCtD
Cevimeline—Urethral disorder—Docetaxel—skin cancer	0.000222	0.000453	CcSEcCtD
Cevimeline—Infection—Fluorouracil—skin cancer	0.000222	0.000452	CcSEcCtD
Cevimeline—Feeling abnormal—Dactinomycin—skin cancer	0.000221	0.00045	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000221	0.00045	CcSEcCtD
Cevimeline—Insomnia—Temozolomide—skin cancer	0.000219	0.000447	CcSEcCtD
Cevimeline—Gastrointestinal pain—Dactinomycin—skin cancer	0.000219	0.000446	CcSEcCtD
Cevimeline—Nervous system disorder—Fluorouracil—skin cancer	0.000219	0.000446	CcSEcCtD
Cevimeline—Thrombocytopenia—Fluorouracil—skin cancer	0.000218	0.000445	CcSEcCtD
Cevimeline—Visual impairment—Docetaxel—skin cancer	0.000218	0.000445	CcSEcCtD
Cevimeline—Tachycardia—Fluorouracil—skin cancer	0.000218	0.000444	CcSEcCtD
Cevimeline—Paraesthesia—Temozolomide—skin cancer	0.000217	0.000443	CcSEcCtD
Cevimeline—Dyspnoea—Temozolomide—skin cancer	0.000216	0.00044	CcSEcCtD
Cevimeline—Somnolence—Temozolomide—skin cancer	0.000215	0.000439	CcSEcCtD
Cevimeline—Dyspepsia—Temozolomide—skin cancer	0.000213	0.000435	CcSEcCtD
Cevimeline—Anorexia—Fluorouracil—skin cancer	0.000213	0.000434	CcSEcCtD
Cevimeline—Eye disorder—Docetaxel—skin cancer	0.000212	0.000432	CcSEcCtD
Cevimeline—Abdominal pain—Dactinomycin—skin cancer	0.000212	0.000432	CcSEcCtD
Cevimeline—Body temperature increased—Dactinomycin—skin cancer	0.000212	0.000432	CcSEcCtD
Cevimeline—Hypersensitivity—Bleomycin—skin cancer	0.000211	0.000431	CcSEcCtD
Cevimeline—Decreased appetite—Temozolomide—skin cancer	0.00021	0.000429	CcSEcCtD
Cevimeline—Cardiac disorder—Docetaxel—skin cancer	0.00021	0.000429	CcSEcCtD
Cevimeline—Flushing—Docetaxel—skin cancer	0.00021	0.000429	CcSEcCtD
Cevimeline—Fatigue—Temozolomide—skin cancer	0.000209	0.000426	CcSEcCtD
Cevimeline—Hypotension—Fluorouracil—skin cancer	0.000208	0.000425	CcSEcCtD
Cevimeline—Constipation—Temozolomide—skin cancer	0.000207	0.000422	CcSEcCtD
Cevimeline—Pain—Temozolomide—skin cancer	0.000207	0.000422	CcSEcCtD
Cevimeline—Asthenia—Bleomycin—skin cancer	0.000206	0.00042	CcSEcCtD
Cevimeline—Angiopathy—Docetaxel—skin cancer	0.000206	0.000419	CcSEcCtD
Cevimeline—Chills—Docetaxel—skin cancer	0.000203	0.000415	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000203	0.000415	CcSEcCtD
Cevimeline—Pruritus—Bleomycin—skin cancer	0.000203	0.000414	CcSEcCtD
Cevimeline—Arrhythmia—Docetaxel—skin cancer	0.000202	0.000413	CcSEcCtD
Cevimeline—Insomnia—Fluorouracil—skin cancer	0.000202	0.000412	CcSEcCtD
Cevimeline—Paraesthesia—Fluorouracil—skin cancer	0.0002	0.000409	CcSEcCtD
Cevimeline—Alopecia—Docetaxel—skin cancer	0.0002	0.000408	CcSEcCtD
Cevimeline—Feeling abnormal—Temozolomide—skin cancer	0.0002	0.000407	CcSEcCtD
Cevimeline—Dyspnoea—Fluorouracil—skin cancer	0.000199	0.000406	CcSEcCtD
Cevimeline—Somnolence—Fluorouracil—skin cancer	0.000198	0.000404	CcSEcCtD
Cevimeline—Gastrointestinal pain—Temozolomide—skin cancer	0.000198	0.000404	CcSEcCtD
Cevimeline—Malnutrition—Docetaxel—skin cancer	0.000197	0.000402	CcSEcCtD
Cevimeline—Hypersensitivity—Dactinomycin—skin cancer	0.000197	0.000402	CcSEcCtD
Cevimeline—Dyspepsia—Fluorouracil—skin cancer	0.000196	0.000401	CcSEcCtD
Cevimeline—Decreased appetite—Fluorouracil—skin cancer	0.000194	0.000396	CcSEcCtD
Cevimeline—Dysgeusia—Docetaxel—skin cancer	0.000193	0.000394	CcSEcCtD
Cevimeline—Urticaria—Temozolomide—skin cancer	0.000192	0.000392	CcSEcCtD
Cevimeline—Asthenia—Dactinomycin—skin cancer	0.000192	0.000392	CcSEcCtD
Cevimeline—Body temperature increased—Temozolomide—skin cancer	0.000191	0.00039	CcSEcCtD
Cevimeline—Abdominal pain—Temozolomide—skin cancer	0.000191	0.00039	CcSEcCtD
Cevimeline—Back pain—Docetaxel—skin cancer	0.000191	0.000389	CcSEcCtD
Cevimeline—Pain—Fluorouracil—skin cancer	0.000191	0.000389	CcSEcCtD
Cevimeline—Muscle spasms—Docetaxel—skin cancer	0.00019	0.000387	CcSEcCtD
Cevimeline—Feeling abnormal—Fluorouracil—skin cancer	0.000184	0.000375	CcSEcCtD
Cevimeline—Diarrhoea—Dactinomycin—skin cancer	0.000183	0.000374	CcSEcCtD
Cevimeline—Vomiting—Bleomycin—skin cancer	0.000182	0.000372	CcSEcCtD
Cevimeline—Anaemia—Docetaxel—skin cancer	0.000182	0.000372	CcSEcCtD
Cevimeline—Rash—Bleomycin—skin cancer	0.000181	0.000369	CcSEcCtD
Cevimeline—Dermatitis—Bleomycin—skin cancer	0.000181	0.000369	CcSEcCtD
Cevimeline—Hypersensitivity—Temozolomide—skin cancer	0.000178	0.000364	CcSEcCtD
Cevimeline—Urticaria—Fluorouracil—skin cancer	0.000177	0.000361	CcSEcCtD
Cevimeline—Syncope—Docetaxel—skin cancer	0.000177	0.000361	CcSEcCtD
Cevimeline—Leukopenia—Docetaxel—skin cancer	0.000177	0.00036	CcSEcCtD
Cevimeline—Body temperature increased—Fluorouracil—skin cancer	0.000176	0.00036	CcSEcCtD
Cevimeline—Palpitations—Docetaxel—skin cancer	0.000174	0.000356	CcSEcCtD
Cevimeline—Asthenia—Temozolomide—skin cancer	0.000174	0.000354	CcSEcCtD
Cevimeline—Loss of consciousness—Docetaxel—skin cancer	0.000173	0.000354	CcSEcCtD
Cevimeline—Cough—Docetaxel—skin cancer	0.000172	0.000351	CcSEcCtD
Cevimeline—Pruritus—Temozolomide—skin cancer	0.000171	0.000349	CcSEcCtD
Cevimeline—Convulsion—Docetaxel—skin cancer	0.000171	0.000349	CcSEcCtD
Cevimeline—Nausea—Bleomycin—skin cancer	0.00017	0.000348	CcSEcCtD
Cevimeline—Hypertension—Docetaxel—skin cancer	0.00017	0.000347	CcSEcCtD
Cevimeline—Vomiting—Dactinomycin—skin cancer	0.00017	0.000347	CcSEcCtD
Cevimeline—Rash—Dactinomycin—skin cancer	0.000169	0.000344	CcSEcCtD
Cevimeline—Arthralgia—Docetaxel—skin cancer	0.000168	0.000343	CcSEcCtD
Cevimeline—Myalgia—Docetaxel—skin cancer	0.000168	0.000343	CcSEcCtD
Cevimeline—Chest pain—Docetaxel—skin cancer	0.000168	0.000343	CcSEcCtD
Cevimeline—Diarrhoea—Temozolomide—skin cancer	0.000166	0.000338	CcSEcCtD
Cevimeline—Hypersensitivity—Fluorouracil—skin cancer	0.000164	0.000335	CcSEcCtD
Cevimeline—Confusional state—Docetaxel—skin cancer	0.000162	0.000331	CcSEcCtD
Cevimeline—Oedema—Docetaxel—skin cancer	0.000161	0.000328	CcSEcCtD
Cevimeline—Dizziness—Temozolomide—skin cancer	0.00016	0.000327	CcSEcCtD
Cevimeline—Infection—Docetaxel—skin cancer	0.00016	0.000326	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—skin cancer	0.000159	0.000324	CcSEcCtD
Cevimeline—Shock—Docetaxel—skin cancer	0.000158	0.000323	CcSEcCtD
Cevimeline—Nervous system disorder—Docetaxel—skin cancer	0.000158	0.000322	CcSEcCtD
Cevimeline—Pruritus—Fluorouracil—skin cancer	0.000158	0.000322	CcSEcCtD
Cevimeline—Thrombocytopenia—Docetaxel—skin cancer	0.000158	0.000322	CcSEcCtD
Cevimeline—Tachycardia—Docetaxel—skin cancer	0.000157	0.000321	CcSEcCtD
Cevimeline—Skin disorder—Docetaxel—skin cancer	0.000156	0.000319	CcSEcCtD
Cevimeline—Vomiting—Temozolomide—skin cancer	0.000154	0.000314	CcSEcCtD
Cevimeline—Anorexia—Docetaxel—skin cancer	0.000153	0.000313	CcSEcCtD
Cevimeline—Rash—Temozolomide—skin cancer	0.000153	0.000311	CcSEcCtD
Cevimeline—Diarrhoea—Fluorouracil—skin cancer	0.000153	0.000311	CcSEcCtD
Cevimeline—Dermatitis—Temozolomide—skin cancer	0.000153	0.000311	CcSEcCtD
Cevimeline—Headache—Temozolomide—skin cancer	0.000152	0.000309	CcSEcCtD
Cevimeline—Hypotension—Docetaxel—skin cancer	0.00015	0.000307	CcSEcCtD
Cevimeline—Dizziness—Fluorouracil—skin cancer	0.000148	0.000301	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000147	0.000299	CcSEcCtD
Cevimeline—Insomnia—Docetaxel—skin cancer	0.000146	0.000297	CcSEcCtD
Cevimeline—Paraesthesia—Docetaxel—skin cancer	0.000145	0.000295	CcSEcCtD
Cevimeline—Nausea—Temozolomide—skin cancer	0.000144	0.000293	CcSEcCtD
Cevimeline—Dyspnoea—Docetaxel—skin cancer	0.000144	0.000293	CcSEcCtD
Cevimeline—Somnolence—Docetaxel—skin cancer	0.000143	0.000292	CcSEcCtD
Cevimeline—Vomiting—Fluorouracil—skin cancer	0.000142	0.000289	CcSEcCtD
Cevimeline—Dyspepsia—Docetaxel—skin cancer	0.000142	0.000289	CcSEcCtD
Cevimeline—Rash—Fluorouracil—skin cancer	0.000141	0.000287	CcSEcCtD
Cevimeline—Dermatitis—Fluorouracil—skin cancer	0.000141	0.000287	CcSEcCtD
Cevimeline—Decreased appetite—Docetaxel—skin cancer	0.00014	0.000285	CcSEcCtD
Cevimeline—Headache—Fluorouracil—skin cancer	0.00014	0.000285	CcSEcCtD
Cevimeline—Fatigue—Docetaxel—skin cancer	0.000139	0.000283	CcSEcCtD
Cevimeline—Pain—Docetaxel—skin cancer	0.000138	0.000281	CcSEcCtD
Cevimeline—Constipation—Docetaxel—skin cancer	0.000138	0.000281	CcSEcCtD
Cevimeline—Feeling abnormal—Docetaxel—skin cancer	0.000133	0.000271	CcSEcCtD
Cevimeline—Nausea—Fluorouracil—skin cancer	0.000132	0.00027	CcSEcCtD
Cevimeline—Gastrointestinal pain—Docetaxel—skin cancer	0.000132	0.000269	CcSEcCtD
Cevimeline—Abdominal pain—Docetaxel—skin cancer	0.000127	0.00026	CcSEcCtD
Cevimeline—Body temperature increased—Docetaxel—skin cancer	0.000127	0.00026	CcSEcCtD
Cevimeline—Hypersensitivity—Docetaxel—skin cancer	0.000119	0.000242	CcSEcCtD
Cevimeline—Asthenia—Docetaxel—skin cancer	0.000116	0.000236	CcSEcCtD
Cevimeline—Pruritus—Docetaxel—skin cancer	0.000114	0.000232	CcSEcCtD
Cevimeline—Diarrhoea—Docetaxel—skin cancer	0.00011	0.000225	CcSEcCtD
Cevimeline—Dizziness—Docetaxel—skin cancer	0.000106	0.000217	CcSEcCtD
Cevimeline—Vomiting—Docetaxel—skin cancer	0.000102	0.000209	CcSEcCtD
Cevimeline—Rash—Docetaxel—skin cancer	0.000102	0.000207	CcSEcCtD
Cevimeline—Dermatitis—Docetaxel—skin cancer	0.000101	0.000207	CcSEcCtD
Cevimeline—Headache—Docetaxel—skin cancer	0.000101	0.000206	CcSEcCtD
Cevimeline—Nausea—Docetaxel—skin cancer	9.56e-05	0.000195	CcSEcCtD
